Indication
Niemann-Pick disease type C
Niemann-Pick disease type C is a rare, life-limiting autosomal recessive neurovisceral lysosomal lipid storage disorder caused by pathogenic variants in either the *NPC1* or *NPC2* gene. Read more about Niemann-Pick disease type C
3 drugs 3 manufacturers
Drugs that treat it
Common Niemann-Pick disease type C therapies.
AQNEURSA (levacetylleucine)
MIPLYFFA (arimoclomol citrate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNiemann-Pick disease type C is a rare, life-limiting autosomal recessive neurovisceral lysosomal lipid storage disorder caused by pathogenic variants in either the *NPC1* or *NPC2* gene.
These genetic defects impair endolysosomal trafficking, resulting in the abnormal intracellular accumulation of unesterified cholesterol and glycosphingolipids across multiple organ systems, predominantly damaging the brain, liver, and spleen.
It can present at any age—from neonates to older adults—with clinical hallmarks that include progressive neurodegeneration, cerebellar ataxia, vertical supranuclear gaze palsy, dysarthria, dysphagia, cognitive impairment, and variable hepatosplenomegaly.
- nih.gov
Niemann-Pick disease type C is a rare, life-limiting autosomal recessive neurovisceral lysosomal lipid storage disorder caused by pathogenic variants in either the *NPC1* or *NPC2* gene
- nih.gov
Niemann-Pick disease type C is a rare, life-limiting autosomal recessive neurovisceral lysosomal lipid storage disorder caused by pathogenic variants in either the *NPC1* or *NPC2* gene These genetic defects impair endolysosomal trafficking, resulting in the abnormal intracellular accumulation of unesterified cholesterol and glycosphingolipids across multiple organ systems, predominantly damaging the brain, liver, and spleen It can present at any age—from neonates to older adults—with clinical h...
- mayoclinic.org
Niemann-Pick disease type C is a rare, life-limiting autosomal recessive neurovisceral lysosomal lipid storage disorder caused by pathogenic variants in either the *NPC1* or *NPC2* gene These genetic defects impair endolysosomal trafficking, resulting in the abnormal intracellular accumulation of unesterified cholesterol and glycosphingolipids across multiple organ systems, predominantly damaging the brain, liver, and spleen It can present at any age—from neonates to older adults—with clinical h...
- medlineplus.gov
These genetic defects impair endolysosomal trafficking, resulting in the abnormal intracellular accumulation of unesterified cholesterol and glycosphingolipids across multiple organ systems, predominantly damaging the brain, liver, and spleen
- medlineplus.gov
It can present at any age—from neonates to older adults—with clinical hallmarks that include progressive neurodegeneration, cerebellar ataxia, vertical supranuclear gaze palsy, dysarthria, dysphagia, cognitive impairment, and variable hepatosplenomegaly
Personalize your experience
Follow Niemann-Pick disease type C and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.